LAM
AMED

Lebenthal Asset Management’s Amedisys AMED Stock Holding History

Lebenthal Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-210
Closed -$10K – 336
2016
Q3 		$10K Buy
+210
New +$10.5K ﹤0.01% 745

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Lebenthal Asset Management's AMED Position: Q4 2016 in Review

Lebenthal Asset Management sold out of Amedisys (AMED) in Q4 2016, closing a stake of 210 shares — an estimated $10K sold.

Lebenthal Asset Management first reported a position in AMED in Q3 2016 and held it in 1 quarter. The position peaked at $10K in Q3 2016. 160 funds tracked by Wall St. Rank hold AMED as of Q4 2016.

  • Lebenthal Asset Management reported no remaining Amedisys position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 210 Amedisys shares in Q4 2016, an estimated $10K.
  • Lebenthal Asset Management first reported a position in Amedisys in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's Amedisys position peaked at $10K in Q3 2016.
  • 160 funds tracked by Wall St. Rank held Amedisys as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.